FITZWILTON HOTEL
Fitzwilton Hotel offers luxurious accommodation, penthouse suites, summer family packages, dining, meetings, events and space services.
FITZWILTON HOTEL
Social Links:
Industry:
Events Hospitality Hotel
Address:
Waterford, Waterford, Ireland
Country:
Ireland
Website Url:
http://www.fitzwiltonhotel.ie
Total Employee:
1+
Status:
Active
Contact:
+353-51-846900
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager Font Awesome Domain Not Resolving Apache
Official Site Inspections
http://www.fitzwiltonhotel.ie
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Fitzwilton Hotel"
Pharma and Biotech M&As in 2025 Roundup - Xtalks
May 5, 2025 Industry analysts project that the momentum in pharma and biotech M&A activity will continue throughout 2025. The combination of financial capacity, strategic necessity due to โฆSee details»
Top 10 Takeover Targets of 2025 - genengnews.com
Feb 3, 2025 Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they โฆSee details»
Bio/Pharma Industry Radar: Top Mergers & Acquisitions Thus Far in 2025
Jul 31, 2025 In June (June 2025), Novartis completed its acquisition of Regulus Therapeutics, a San Diego, California-based clinical-stage bio/pharmaceutical company developing microRNA โฆSee details»
2025 biotech deals: the Labiotech tracker
Stay ahead in 2025 with the latest biotech deals. Discover key collaborations, M&A, and strategic moves shaping the industry's future.See details»
2025 Acquisition Targets โ FinForecasts
Itโs important to note that while these companies are mentioned as potential targets, thereโs no guarantee they will be acquired. Investors should conduct their own research and consider the โฆSee details»
Biotech and Pharma M&A: 2025 Outlook | AlphaSense
Following a year of smaller deals in 2024, the biotechnology and pharmaceutical sectors began the year poised for a resurgence in mergers and acquisitions in 2025 โ though growing โฆSee details»
Big Pharma M&As: What to Expect in 2025 - definitivehc.com
Apr 30, 2025 After a sluggish 2024, many in the life sciences world hoped 2025 would usher in a revival for big-ticket biopharma mergers and acquisitions. But as the first quarter has closed, โฆSee details»
January 2025 Wave of Mergers and Acquisitions in the โฆ
Feb 19, 2025 Both parties anticipate signing the final agreement no later than February 28, 2025, and the merged company will focus on accelerating drug discovery, reducing โฆSee details»
Pfizerโs $6 Billion Acquisition: A Game-Changer in Cancer โฆ
May 20, 2025 In a landmark move that could reshape oncology care, Pfizer announced today its $6 billion acquisition of global rights to 3SBioโs breakthrough cancer therapy.See details»
Surge in Biotech Mergers & Acquisitions: What 2025 Holds for the Pharma โฆ
Feb 14, 2025 In this article, we will explore the current trends fueling this M&A momentum and examine the future implications for the pharma industry. The biotech industry is experiencing a โฆSee details»